DAVIDA KRUGER: Open Payments
NPI 1497897961 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208,466 in 261 payments from 13 companies in 2025. Trend: 2023 $152,656 · 2024 $103,423 · 2025 $208,466
Speaker / faculty: $86,298Consulting: $52,546Speaker / faculty: $38,236Travel & lodging: $18,779Food & beverage: $6,733Honoraria: $5,875
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 45 | $64,432 |
| Insulet Corporation | 80 | $44,695 |
| Abbott Laboratories | 82 | $42,582 |
| Dexcom, Inc. | 13 | $25,475 |
| Lilly USA, LLC | 10 | $7,360 |
| Corcept Therapeutics | 3 | $5,175 |
| Sequel Med Tech, LLC | 6 | $4,101 |
| SANOFI-AVENTIS U.S. LLC | 10 | $3,874 |
| Mannkind Corporation | 5 | $3,737 |
| Tandem Diabetes Care, Inc. | 2 | $2,633 |
Products named: Ozempic, OMNIPOD, FREESTYLE LIBRE 3, DEXCOM G7 GSS (161), MOUNJARO, Korlym, Rybelsus, TWIIST.
Industry payments across MI — which companies pay providers there.
